This multicenter study evaluated the tolerance and potential pharmacokinetic interactions between azithromycin and rifabutin in volunteers with or without human immunodeficiency virus infection. Daily dosing with the combination of azithromycin and rifabutin was poorly tolerated, primarily because of gastrointestinal symptoms and neutropenia. No significant pharmacokinetic interactions were found between these drugs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC90510 | PMC |
| http://dx.doi.org/10.1128/AAC.45.5.1572-1577.2001 | DOI Listing |
Publication Analysis
Top Keywords
pharmacokinetic interactions
12
azithromycin rifabutin
8
tolerance pharmacokinetic
4
interactions rifabutin
4
rifabutin azithromycin
4
azithromycin multicenter
4
multicenter study
4
study evaluated
4
evaluated tolerance
4
tolerance potential
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!